The type 1 diabetes–associated 12q13 SNPs in two independent cohorts
SNP | Minor allele | Frequency | Informative families* | S† | E(S)‡ | Var(S)§ | Z | P |
---|---|---|---|---|---|---|---|---|
Consortium set | ||||||||
rs773107 | G | 0.322 | 217 | 329 | 290 | 208 | 2.73 | 0.006400 |
rs10876864 | G | 0.417 | 226 | 395 | 350 | 229 | 2.98 | 0.002885 |
rs1701704 | C | 0.346 | 216 | 341 | 296 | 211 | 3.09 | 0.002019 |
Canadian set | ||||||||
rs773107 | G | 0.339 | 200 | 180 | 160 | 75 | 2.37 | 0.017736 |
rs10876864 | G | 0.452 | 212 | 210 | 191 | 87 | 2.09 | 0.036293 |
rs1701704 | C | 0.357 | 216 | 189 | 169 | 81 | 2.22 | 0.026268 |
Combined | ||||||||
rs773107 | G | 0.329 | 417 | 509 | 449 | 283 | 3.56 | 0.000374 |
rs10876864 | G | 0.432 | 438 | 605 | 540 | 316 | 3.64 | 0.000278 |
rs1701704 | C | 0.350 | 432 | 530 | 465 | 292 | 3.80 | 0.000148 |
* Number of nuclear families informative for (with a non-zero contribution to) FBAT analysis.
† Observed allele number in the affected offspring.
‡ Expected allele number in the affected offspring.
§ Variance of allele distribution among the affected offspring.